RT Journal Article
SR Electronic
T1 Infection Units: A novel approach to the modeling of COVID-19 spread
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.01.21256433
DO 10.1101/2021.05.01.21256433
A1 Jose C. Merchuk
A1 Francisco García-Camacho
A1 Lorenzo López-Rosales
YR 2021
UL http://medrxiv.org/content/early/2021/05/04/2021.05.01.21256433.abstract
AB A novel mechanistic model describing the rate of COVID-19 spread is presented, that differs conceptually from previously published deterministic models. One of its main characteristics is that the pool of infected people is not assumed to be homogeneously mixed, but rather as a passage into which individuals enter upon contagion, move within it in a plug-flow manner and leave at recovery, within a fixed time period. So, the present model differs conceptually in the way it describes the dynamics of infection. An ‘infection unit’ is defined as the amount of COVID-19 virus that generates contagion, if it reaches a susceptible individual. This model separately considers various pools: symptomatic and asymptomatic infected patients; three different pools of recovered individuals; pools of assisted, hospitalized patients; the quarantined and, finally, those who died from COVID-19. The transmission of the disease from an infected person to others is described by an infection rate function, while an encounter frequency function modulates the frequency of effective encounters between the infected and the susceptible. The influence of the model’s parameters on the predicted results is presented. The effect of social restrictions and of quarantine policy on pandemic spread is shown. For model calibration, a set of experimental data is used. The model enables the calculation of the actual behaviour of the studied pools during pandemic spread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:-All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe relevant data are included in the MS